INTERNATIONAL PATENT: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, SHOR, BORIS FILES APPLICATION FOR "POTENT FGFR4-TARGETED ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR TREATING CANCERS EXPRESSING FGFR4"

GENEVA, Oct. 15 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (6701 Rockledge DriveSuite 700, MSC 7788Bethesda, Maryland 20892-7788), THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (35 State StreetAlbany, New York 12207), SHOR, Boris (Manhattan BioSolutions, Inc.101 6th Ave 3rd floorNew York, New York 10013) filed a patent application (PCT/US2025/023122) for "POTENT FGFR4-TARGETED ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR TREATING CANCERS EXPRESSING FGFR4" on Apr 04, 2025. With publication no. WO/2025/212999, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Class...